Aligned Genetics Inc (KQ:238120) — Market Cap & Net Worth
Market Cap & Net Worth: Aligned Genetics Inc (238120)
Aligned Genetics Inc (KQ:238120) has a market capitalization of $29.34 Million (₩43.30 Billion) as of September 19, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #23955 globally and #1679 in its home market, demonstrating a 3.18% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Aligned Genetics Inc's stock price ₩3080.00 by its total outstanding shares 14058274 (14.06 Million). Also see 238120 total assets for a full breakdown of the balance sheet.
Aligned Genetics Inc Market Cap History: 2016 to 2026
Aligned Genetics Inc's market capitalization history from 2016 to 2026. Data shows change from $40.61 Million to $29.34 Million (-5.41% CAGR). Also see Aligned Genetics Inc (238120) cash flow conversion for how efficiently the company converts equity into cash flow.
Index Memberships
Aligned Genetics Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$235.78 Billion | 0.01% | #859 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$235.78 Billion | 0.01% | #859 of 1384 |
Weight: Aligned Genetics Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Aligned Genetics Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Aligned Genetics Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Aligned Genetics Inc (238120) stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.00x
Aligned Genetics Inc's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.01x
Aligned Genetics Inc's market cap is 0.01 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $40.61 Million | $4.71 Billion | -$1.56 Billion | 0.01x | N/A |
| 2017 | $29.65 Million | $5.64 Billion | -$1.75 Billion | 0.01x | N/A |
| 2018 | $31.20 Million | $5.68 Billion | -$1.59 Billion | 0.01x | N/A |
| 2019 | $32.27 Million | $7.79 Billion | $116.74 Million | 0.00x | 0.28x |
| 2020 | $47.16 Million | $7.96 Billion | $468.23 Million | 0.01x | 0.10x |
| 2021 | $40.82 Million | $11.76 Billion | $5.54 Billion | 0.00x | 0.01x |
| 2022 | $35.87 Million | $13.75 Billion | $2.33 Billion | 0.00x | 0.02x |
| 2023 | $38.39 Million | $15.21 Billion | $3.24 Billion | 0.00x | 0.01x |
| 2024 | $28.82 Million | $15.78 Billion | $4.13 Billion | 0.00x | 0.01x |
Competitor Companies of 238120 by Market Capitalization
Companies near Aligned Genetics Inc in the global market cap rankings as of September 19, 2026. Review 238120 tangible net assets ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Aligned Genetics Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #124 globally with a market cap of $178.43 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #238 globally with a market cap of $105.53 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #124 | Abbott Laboratories | NYSE:ABT | $178.43 Billion | $102.61 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.13 |
| #238 | Stryker Corporation | NYSE:SYK | $105.53 Billion | $275.12 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Aligned Genetics Inc Historical Marketcap From 2016 to 2026
Between 2016 and today, Aligned Genetics Inc's market cap moved from $40.61 Million to $ 29.34 Million, with a yearly change of -5.41%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩29.34 Million | -20.41% |
| 2025 | ₩36.87 Million | +27.93% |
| 2024 | ₩28.82 Million | -24.94% |
| 2023 | ₩38.39 Million | +7.04% |
| 2022 | ₩35.87 Million | -12.14% |
| 2021 | ₩40.82 Million | -13.43% |
| 2020 | ₩47.16 Million | +46.13% |
| 2019 | ₩32.27 Million | +3.44% |
| 2018 | ₩31.20 Million | +5.22% |
| 2017 | ₩29.65 Million | -26.98% |
| 2016 | ₩40.61 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of Aligned Genetics Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $29.34 Million USD |
| MoneyControl | $29.34 Million USD |
| MarketWatch | $29.34 Million USD |
| marketcap.company | $29.34 Million USD |
| Reuters | $29.34 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Aligned Genetics Inc
Aligned Genetics, Inc. offers cellular imaging and biomolecular analysis solutions worldwide. It also provides molecular diagnostic solutions for rapid results under the Genescale name; and advanced imaging and analysis solutions under the Logos Biosystems name. The company was formerly known as Logos Biosystems, Inc. and changed its name to Aligned Genetics, Inc. in September 2020. Aligned Genet… Read more